What is the clinical profile and lesion in young patients with myocardial infarction (MI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Profile and Lesions in Young Patients with Myocardial Infarction

Young patients with myocardial infarction (MI) present with distinct risk factor profiles, clinical presentations, and coronary lesion characteristics compared to older patients, with smoking being the predominant modifiable risk factor in this population. 1, 2

Clinical Presentation

  • Young patients (≤55 years) with MI are equally likely to present with chest pain as older patients, with chest pain remaining the predominant symptom (87-89.5% of young patients) 3
  • Young patients, particularly women, more frequently report associated symptoms compared to older patients, including:
    • Epigastric symptoms
    • Palpitations
    • Pain or discomfort in the jaw, neck, arms, or between shoulder blades
    • 61.9% of young women vs. 54.8% of young men report these associated symptoms 3
  • Young patients are more likely to be diagnosed with ST-segment elevation myocardial infarction (STEMI) compared to older patients (62.0% vs. 50.0%) 1

Demographic Characteristics

  • Young MI patients are predominantly male (86.3% vs. 65.8% in older patients) 1
  • Young patients typically have higher body weight compared to older patients (mean 85.9 kg vs. 79.7 kg) 1
  • The relative number of MI cases in young patients is increasing (from 1.20% in 2014 to 1.43% in 2017) 1

Risk Factor Profile

  • Traditional cardiovascular risk factors are generally less prevalent in young MI patients compared to older patients, with notable exceptions 2, 4
  • Smoking is the most significant modifiable risk factor in young MI patients:
    • 37.5% of young patients are current smokers vs. 23.0% of older patients 1
    • Up to 73.8% of young MI patients have a smoking history 5
  • Family history of premature coronary artery disease (CAD) is common (44.3% of young MI patients) 5
  • Dyslipidemia affects 39.35% of young MI patients, often presenting as familial combined hyperlipidemia with elevated lipoprotein-a levels 2, 5
  • Hypertension is present in 37.7% of young MI patients 5
  • Obesity affects 11.5% of young MI patients 5
  • Diabetes mellitus is less common in young MI patients (8.2%) compared to older populations 5
  • Sedentary lifestyle is highly prevalent among young MI patients 5
  • Substance use may play a significant role:
    • Cannabis, cocaine, and androgenic anabolic steroids are more commonly associated with MI in younger patients 2

Coronary Lesion Characteristics

  • Young MI patients more frequently have the left anterior descending artery (LAD) as the infarct-related artery (51.3% vs. 36.3% in older patients) 1
  • Non-significant coronary stenosis is more common in young MI patients (14.4% vs. 6.8% in older patients) 1
  • Young patients typically have fewer atherosclerotic lesions but more eccentric plaques with inflammatory features 2
  • Unique pathophysiological mechanisms more common in young patients include:
    • Plaque erosion rather than plaque rupture
    • Coronary microvascular dysfunction
    • Spontaneous coronary artery dissection
    • Coronary vasospasm related to drug use 4

Diagnostic and Treatment Considerations

  • Young MI patients should be evaluated for both traditional and non-traditional risk factors, with particular attention to smoking status, family history, and substance use 2, 4
  • Bioresorbable vascular scaffolds are more commonly used in young MI patients compared to older patients (5.6% vs. 0.9%) 1
  • Genetic testing may be beneficial as genomic differences in coagulation and lipid metabolism pathways have been identified between young and older MI patients 2
  • Risk assessment tools should be carefully applied, as they may underestimate risk in young patients, particularly women 3

Prevention Strategies

  • Aggressive smoking cessation interventions are crucial for primary and secondary prevention in young adults 1, 5
  • Screening for familial hyperlipidemia should be considered in young adults with family history of premature CAD 2
  • Lifestyle modifications addressing sedentary behavior, obesity, and substance use are particularly important in this population 2, 5
  • Early identification of young individuals at increased risk can guide targeted primary prevention strategies 2

References

Research

Acute myocardial infarction in young patients.

Kardiologia polska, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute Myocardial Infarction in Young Individuals.

Mayo Clinic proceedings, 2020

Related Questions

What is the initial management for a young patient with myocardial infarction (MI), based on clinical, biochemical, and angiography profile?
What is the diagnosis for a 68-year-old male presenting with complaints of chest pain and shortness of breath (SOB) for 2 weeks, status post myocardial infarction (heart attack) with surgical intervention twice?
What is the most appropriate medication to relieve chest pain in a patient with ST segment elevation, tachycardia, and hypertension, who has been administered aspirin?
What is the initial management for a patient with Acute Coronary Myocardial Infarction (AC MI)?
What is the next step for a 64-year-old patient presenting with chest pain for 2 days, ECG showing ST depression in leads 2 and 3, and negative troponin I (Trop I)?
What are the fewer side effects of sulpiride (antipsychotic medication) and how is that relevant to elderly patients?
Why is an infrarenal abdominal aortic aneurysm (AAA) with ulcerated plaques considered a chronic aortoiliac disease rather than an acute aortic syndrome?
Why is haloperidol (antipsychotic) preferred over sulpiride (atypical antipsychotic) in treating emergency ballism in a young patient?
Is haloperidol (antipsychotic) risky in patients with movement disorders due to basal ganglia lesions?
Is intermittent Haloperidol (antipsychotic medication) safe for anesthesia-induced ballism in a patient with hyperdopaminergic choreoathetosis?
What is the recommended dose of Nitrofurantoin (antibiotic) for an uncomplicated urinary tract infection (UTI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.